| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.006 |